Amylyx Pharmaceuticals Inc
Officers & Directors
Joshua B. Cohen
Co-Chief Executive Officer and Director (Principal Executive Officer)
Joshua is a co-founder of Amylyx and serves as its CEO. He is responsible for managing the organization s business strategy, fundraising, and creating partnerships to further the development of its pipeline of therapies. He holds an MBA from MIT Sloan School of Management and a BA from Dartmouth College.
Justin B. Klee
Co-Chief Executive Officer and Director (Principal Executive Officer)
Justin is a co-founder of Amylyx and serves as its Co-CEO. He manages the research and development of the organization s drugs and has a Ph.D. from the University of California, San Diego.
James M. Frates
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
Karen Firestone
Director
George Mclean Milne Jr.
Director
Daphne Quimi
Director
Paul Fonteyne
Director
8. Richard Peters
Independent Board Member
Dr. Peters has over 25 years of experience in the pharmaceutical industry and has held senior executive positions at several organizations, including ACADIA Pharmaceuticals and Eli Lilly and Company.
9. William Hawkins
Independent Board Member
Mr. Hawkins has over 35 years of experience in the healthcare industry and previously served as the CEO of Medtronic.
10. Robert Tepper
Independent Board Member
Dr. Tepper is the co-founder and Chief Scientific Officer of Longwood Fund, a healthcare-focused venture capital firm. He has over 30 years of experience in drug discovery and development, including serving as the President and Chief Scientific Officer of Proteostasis Therapeutics.,
Amylyx Pharmaceuticals Inc currently has 136 employees.
|
